Evaluating the Effects of Platelet‐Rich Plasma and Amniotic Viscous Fluid on Inflammatory Markers in a Human Coculture Model for Osteoarthritis
Authors:
- 1 August 2019
- journal article
- research article
- Published by Wiley in Arthroscopy
- Vol. 35 (8) , 2421-2433
Abstract
Purpose: To assess the anti‐inflammatory effects of platelet‐rich plasma (PRP) and amniotic viscous fluid using a human coculture system of cartilage and synovial tissue from osteoarthritic patients. Methods: A coculture system was created using cartilage and synovium from 3 patients undergoing total knee arthroplasty. To induce inflammation, interleukin‐1β was added to each coculture. Biologic agents tested included 2 PRP concentrations (PRP L and PRP H ) and 2 different samples of amniotic viscous fluid (Amnion and Flograft). Amnion was also tested with PRP to check for any additive effects. Quantitative polymerase chain reaction was used to measure gene expression of factors involved in osteoarthritis, including disintegrin and metalloproteinase with thrombospondin motifs‐5 (ADAMTS‐5), tissue inhibitor of metalloproteinases 1 (TIMP‐1), vascular endothelial growth factor (VEGF), aggrecan, type 1 collagen, and nitric oxide, at 0, 24, 48, and 72 hours. A synthetic nonsteroidal medication, Ketorolac, was used for baseline comparison to the biologic agents. Results: When comparing from time 0, both Amnion and Flograft resulted in significant decreases of ADAMTS‐5 and TIMP‐1 gene expression in cartilage and synovium for up to 72 hours. Both amniotic preparations increased collagen‐1 gene expression in cartilage and decreased VEGF expression in synovium. Amnion was not found to have any effect on nitric oxide concentration at any time point ( P > .05), as opposed to both PRP concentrations ( P < .05). All biologic agents showed differences in gene expression similar to Ketorolac in ADAMTS‐5, TIMP‐1, and VEGF expression. Conclusion: This study found that amniotic fluid had anti‐inflammatory effects mostly similar to those of both PRP H and PRP L ; however, no significant additive effects in reducing inflammatory gene expression were found when combining biologic agents. Clinical Relevance: PRP and amniotic fluid may provide alternative treatment options to delay the progression of the disease without the systemic and intra‐articular side effects of corticosteroids.Keywords
This publication has 32 references indexed in Scilit:
- Platelet-Rich Plasma Increases Anti-inflammatory Markers in a Human Coculture Model for OsteoarthritisThe American Journal of Sports Medicine, 2015
- Properties of dehydrated human amnion/chorion composite grafts: Implications for wound repair and soft tissue regenerationJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2014
- The Anti-inflammatory and Matrix Restorative Mechanisms of Platelet-Rich Plasma in OsteoarthritisThe American Journal of Sports Medicine, 2013
- Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)Osteoarthritis and Cartilage, 2013
- Amniotic membrane: from structure and functions to clinical applicationsCell and tissue research, 2012
- The effect of local anesthetic and corticosteroid combinations on chondrocyte viabilityKnee Surgery, Sports Traumatology, Arthroscopy, 2011
- Does intraarticular steroid infiltration increase the rate of infection in subsequent total knee replacements?The Knee, 2009
- Review of In Vitro Models and Development and Initial Validation of a Novel Co-Culture Model for the Study of OsteoarthritisCurrent Rheumatology Reviews, 2007
- Growth factor mRNA and protein in preserved human amniotic membraneCurrent Eye Research, 2000
- Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritisOsteoarthritis and Cartilage, 1995